DK1467737T3 - Oralt dispergerbar farmaceutisk sammensætning indeholdende piribedil - Google Patents

Oralt dispergerbar farmaceutisk sammensætning indeholdende piribedil

Info

Publication number
DK1467737T3
DK1467737T3 DK03709892T DK03709892T DK1467737T3 DK 1467737 T3 DK1467737 T3 DK 1467737T3 DK 03709892 T DK03709892 T DK 03709892T DK 03709892 T DK03709892 T DK 03709892T DK 1467737 T3 DK1467737 T3 DK 1467737T3
Authority
DK
Denmark
Prior art keywords
piribedil
pharmaceutical composition
composition containing
orally dispersible
dispersible pharmaceutical
Prior art date
Application number
DK03709892T
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1467737T3 publication Critical patent/DK1467737T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK03709892T 2002-01-21 2003-01-21 Oralt dispergerbar farmaceutisk sammensætning indeholdende piribedil DK1467737T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil

Publications (1)

Publication Number Publication Date
DK1467737T3 true DK1467737T3 (da) 2006-09-18

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03709892T DK1467737T3 (da) 2002-01-21 2003-01-21 Oralt dispergerbar farmaceutisk sammensætning indeholdende piribedil

Country Status (27)

Country Link
US (1) US20050085485A1 (da)
EP (1) EP1467737B1 (da)
JP (1) JP4500051B2 (da)
KR (1) KR100588223B1 (da)
CN (1) CN100352440C (da)
AR (1) AR038194A1 (da)
AT (1) ATE327758T1 (da)
AU (1) AU2003214326B2 (da)
BR (1) BR0306869A (da)
CA (1) CA2473152C (da)
CY (1) CY1105414T1 (da)
DE (1) DE60305642T2 (da)
DK (1) DK1467737T3 (da)
EA (1) EA007286B1 (da)
ES (1) ES2263959T3 (da)
FR (1) FR2834894B1 (da)
GE (1) GEP20063819B (da)
HK (1) HK1081110A1 (da)
MA (1) MA27098A1 (da)
MX (1) MXPA04007035A (da)
NO (1) NO20043474L (da)
NZ (1) NZ533820A (da)
PL (1) PL204939B1 (da)
PT (1) PT1467737E (da)
UA (1) UA78277C2 (da)
WO (1) WO2003061661A1 (da)
ZA (1) ZA200405008B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (da) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
EP0745382B1 (en) * 1994-01-31 2003-11-12 Yamanouchi Pharmaceutical Co. Ltd. Intraorally soluble compressed molding and process for producing the same
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
WO2002007957A2 (en) * 2000-07-24 2002-01-31 Boehringer Ingelheim Pharmaceuticals, Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
UA78277C2 (en) 2007-03-15
KR100588223B1 (ko) 2006-06-12
AR038194A1 (es) 2005-01-05
ATE327758T1 (de) 2006-06-15
DE60305642T2 (de) 2007-05-16
MA27098A1 (fr) 2004-12-20
JP4500051B2 (ja) 2010-07-14
CY1105414T1 (el) 2010-04-28
JP2005529068A (ja) 2005-09-29
PL204939B1 (pl) 2010-02-26
HK1081110A1 (en) 2006-05-12
CN100352440C (zh) 2007-12-05
ZA200405008B (en) 2005-08-31
ES2263959T3 (es) 2006-12-16
MXPA04007035A (es) 2004-10-11
EA200400885A1 (ru) 2004-12-30
FR2834894A1 (fr) 2003-07-25
EA007286B1 (ru) 2006-08-25
EP1467737A1 (fr) 2004-10-20
NO20043474L (no) 2004-08-20
GEP20063819B (en) 2006-05-10
DE60305642D1 (de) 2006-07-06
WO2003061661A1 (fr) 2003-07-31
FR2834894B1 (fr) 2004-02-27
CA2473152A1 (fr) 2003-07-31
AU2003214326B2 (en) 2007-08-02
US20050085485A1 (en) 2005-04-21
EP1467737B1 (fr) 2006-05-31
CN1688313A (zh) 2005-10-26
BR0306869A (pt) 2004-11-03
NZ533820A (en) 2005-08-26
KR20040075098A (ko) 2004-08-26
PL370168A1 (en) 2005-05-16
PT1467737E (pt) 2006-08-31
CA2473152C (fr) 2010-08-31

Similar Documents

Publication Publication Date Title
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
DK2446881T3 (da) Oral opløselige film
PT1501534E (pt) Formulacoes farmaceuticas
NO20052335D0 (no) Dispergerbare defracirox-tabletter
ATE380544T1 (de) Umhüllte feste darreichungsform
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
ATE296619T1 (de) Feste orale dosierungsform von simethicon
FI20011478A (fi) Farmaseuttinen koostumus
NO20033384D0 (no) Farmasöytisk formulering
NO20033785L (no) Farmasöytisk formulering
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
EE200300589A (et) Ravimkoostised
NO20035627D0 (no) Farmasöytisk formulering
FI20022128A (fi) Farmaseuttinen koostumus
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1467737T3 (da) Oralt dispergerbar farmaceutisk sammensætning indeholdende piribedil
DE10291905D2 (de) Pharmazeutische Zusammensetzung
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DK1653963T3 (da) Nasal farmaceutisk sammensætning piribedil
AU2003214326A1 (en) Orally dispersible pharmaceutical piribedil composition
NO20044164L (no) Farmasoytiske sammensetninger
SI1467737T1 (sl) Farmacevtski sestavek piribedila za dispergiranjev ustih
DE10107261B4 (de) Pharmazeutische Zusammensetzung
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti
DOP2002000508A (es) Composición farmaceutica